-
Simvastatin (Zocor): Assay Design by Phenotype
2026-08-25
Simvastatin (Zocor) can serve as both a cholesterol synthesis perturbation and a mechanistic benchmark in cell-based research. This guide shows how to design cross-cell-line assays that separate HMG-CoA reductase biology from context-dependent phenotypes.
-
Phytol: From RXR Mechanism to Translational Strategy
2026-08-25
Phytol is more than a natural diterpene alcohol: its RXR activity, GABAergic effects, and metabolism to phytanic acid create both translational opportunities and experimental liabilities. This article outlines how researchers can turn that mechanistic complexity into a disciplined validation and development strategy.
-
Chlorpromazine HCl: Mechanism and Research Uses
2026-08-24
Chlorpromazine HCl is a phenothiazine dopamine receptor antagonist used in receptor pharmacology, electrophysiology, and psychotic disorder research. Product data support defined solvent solubility, cell-assay concentrations, and storage conditions, while recent phenothiazine research provides a separate framework for studying macrophage ROS and autophagy.
-
Phosbind Acrylamide Workflow for Phosphorylation
2026-08-24
Phosbind Acrylamide enables antibody-independent separation of phosphorylated and non-phosphorylated proteins directly during SDS-PAGE. This workflow applies that capability to ISR research, kinase assays, and pathway studies while emphasizing controls, gel optimization, and interpretation limits.
-
PLAC1 in Clear Cell Renal Cell Carcinoma
2026-08-23
The reference study identifies PLAC1 as an overexpressed, adverse prognostic marker and functional contributor in clear cell renal cell carcinoma. By combining TCGA analysis, protein-level validation, PLAC1 knockdown, and high-throughput virtual screening, the authors nominate Amaronol B and canagliflozin as candidate compounds for PLAC1-directed investigation.
-
Protoporphyrin IX for Photodynamic Assays
2026-08-22
Protoporphyrin IX connects photodynamic readouts with heme and iron biology, enabling controlled studies of cancer-cell vulnerability and ferroptosis resistance. This workflow emphasizes fresh preparation, light-matched controls, formulation validation, and mechanistic interpretation in the context of the METTL16-SENP3-LTF axis.
-
Ciprofloxacin Beyond Antibiotics: A Nanotheranostic Lens
2026-08-21
Ciprofloxacin is best known as a fluoroquinolone antibiotic, but emerging nanomedicine research positions it as a sonosensitizer within ultrasound-guided cancer theranostics. This article translates that finding into practical assay decisions while distinguishing established antibacterial biology from an early oncology application.
-
Morning Training Improves Endurance Adaptation in Mice
2026-08-20
Hesketh et al. show that endurance training during the early active phase produces faster and more efficient performance adaptation than training later in the active phase, despite lower absolute training volumes. The study links this timing effect to skeletal-muscle metabolic and contractile remodeling rather than to differences in glycogen content, providing an important framework for circadian exercise research.
-
Indomethacin Sodium Trihydrate Assays
2026-08-20
A scenario-driven guide to using Indomethacin Sodium Trihydrate, SKU C6491, in cell viability, proliferation, differentiation, and inflammation assays. It covers formulation choice, concentration design, controls, data interpretation, storage, and practical vendor-selection criteria.
-
Tropisetron Hydrochloride: Assay Workflows
2026-08-19
Build cleaner receptor and renal transporter experiments with Tropisetron Hydrochloride, a selective 5-HT3 receptor antagonist that also engages α7-nicotinic receptor signaling. This guide translates receptor pharmacology and OCT2/MATE1 transport findings into practical assay design, controls, and troubleshooting decisions.
-
RNA Pol II Loss Activates Apoptosis Beyond Transcription
2026-08-19
Harper et al. show that RNA polymerase II inhibition kills cells through an active apoptotic response to loss of hypophosphorylated RNA Pol IIA, rather than through passive mRNA and protein depletion. Their genetic and chemical analyses define the Pol II degradation-dependent apoptotic response (PDAR), a framework that may clarify why diverse transcription-targeting drugs are cytotoxic.
-
Higher-Concentration LNPs Improve mRNA Expression
2026-08-18
The reference study shows that intensified confined jet-impingement mixing can produce mRNA lipid nanoparticles from substantially more concentrated lipid and RNA starting materials without sacrificing key particle-quality attributes. Higher-concentration formulations also improved in vivo expression, biodistribution, morphology, and storage stability, although buffer composition remained a major determinant of performance.
-
Dual-Action Inhibitors Tune p38α Dephosphorylation
2026-08-18
A Brandeis University preprint shows that selected kinase inhibitors can both inhibit p38α activity and accelerate WIP1-mediated dephosphorylation by stabilizing an activation-loop conformation with an exposed phospho-threonine. The work provides a structural framework for designing inhibitors that influence kinase signaling through both immediate active-site blockade and enhanced pathway shutoff.
-
Tamoxifen Workflows for CreER and Cancer Research
2026-08-17
Tamoxifen connects ligand-controlled CreER-mediated gene knockout with estrogen-receptor pharmacology in breast cancer research. This practical guide covers formulation, induction design, assay controls, and the developmental-risk lessons that help distinguish intended recombination from off-target drug effects.
-
Tropisetron Hydrochloride: A Two-Axis Assay Map
2026-08-17
Tropisetron Hydrochloride is a selective 5-HT3 receptor antagonist with additional α7-nicotinic receptor activity. This article develops an evidence-based assay framework that separates receptor pharmacology from OCT2/MATE1 transporter effects for more defensible neuroscience and renal secretion studies.